These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8210705)

  • 1. Successful mass vaccination against hepatitis B virus in a hyperendemic area in Italy.
    Da Villa G
    Res Virol; 1993; 144(4):255-8. PubMed ID: 8210705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project.
    Da Villa G; Piccinino F; Scolastico C; Fusco M; Piccinino R; Sepe A
    Res Virol; 1998; 149(5):263-70. PubMed ID: 9879603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas.
    Da Villa G; Piazza M; Iorio R; Picciotto L; Peluso P; De Luca G; Basile B
    J Med Virol; 1992 Apr; 36(4):274-8. PubMed ID: 1578220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence.
    Lin CL; Kao JH
    Gastroenterol Clin North Am; 2020 Jun; 49(2):201-214. PubMed ID: 32389359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.
    Chang MH; Chen DS
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):511-7. PubMed ID: 10654916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From hepatitis to hepatoma: lessons from type B viral hepatitis.
    Chen DS
    Science; 1993 Oct; 262(5132):369-70. PubMed ID: 8211155
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
    Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
    Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on the role of epidemiology in the investigation of hepatitis B virus.
    London WT; Blumberg BS
    Epidemiol Rev; 1985; 7():59-79. PubMed ID: 2996918
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B, hepatocellular carcinoma, and strategies for prevention.
    Arthur MJ; Hall AJ; Wright R
    Lancet; 1984 Mar; 1(8377):607-10. PubMed ID: 6142315
    [No Abstract]   [Full Text] [Related]  

  • 15. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B: the incidence of carriers and the initial experience of mass vaccination in the police].
    Cioli S; Cordelli A; Sardone D; Giannelli G; Lalli CG; Maresca A; Pioda GB; Lanzetta BM; D'Annibali E
    G Ital Med Lav; 1990; 12(2-4):81-5; discussion 85-6. PubMed ID: 2152608
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
    Zuckerman AJ
    Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
    [No Abstract]   [Full Text] [Related]  

  • 20. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
    Larouzé B; Blumberg BS; London WT; Lustbader ED; Sankalé M; Payet M
    J Natl Cancer Inst; 1977 Jun; 58(6):1557-61. PubMed ID: 68119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.